Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ERP

TI reports first quarter 2024 financial results and shareholder returns


DALLAS, April 23, 2024 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) today reported first quarter revenue of $3.66 billion, net income of $1.11 billion and earnings per share of $1.20.  Earnings per share included a 10-cent benefit for items that were not in the company's original guidance.

Regarding the company's performance and returns to shareholders, Haviv Ilan, TI's president and CEO, made the following comments:

Free cash flow, a non-GAAP financial measure, is cash flow from operations less capital expenditures.

Earnings summary

(In millions, except per-share amounts)


Q1 2024


Q1 2023


Change?

Revenue


$

3,661


$

4,379


(16) %

Operating profit


$

1,286


$

1,934


(34) %

Net income


$

1,105


$

1,708


(35) %

Earnings per share


$

1.20


$

1.85


(35) %

 

Cash generation






Trailing 12 Months

(In millions)


Q1 2024


Q1 2024


Q1 2023


Change?

Cash flow from operations


$

1,017


$

6,277


$

7,736


(19) %

Capital expenditures


$

1,248


$

5,337


$

3,336


60 %

Free cash flow


$

(231)


$

940


$

4,400


(79) %

Free cash flow % of revenue






5.6 %



22.6 %



 

Cash return






Trailing 12 Months

(In millions)


Q1 2024


Q1 2024


Q1 2023


Change?

Dividends paid


$

1,183


$

4,615


$

4,359


6 %

Stock repurchases


$

3


$

193


$

3,129


(94) %

Total cash returned


$

1,186


$

4,808


$

7,488


(36) %

 

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Statements of Income


For Three Months Ended

March 31,

(In millions, except per-share amounts)


2024


2023

Revenue


$

3,661


$

4,379

Cost of revenue (COR)



1,566



1,516

Gross profit



2,095



2,863

Research and development (R&D)



478



455

Selling, general and administrative (SG&A)



455



474

Restructuring charges/other



(124)



?

Operating profit



1,286



1,934

Other income (expense), net (OI&E)



123



80

Interest and debt expense



116



68

Income before income taxes



1,293



1,946

Provision for income taxes



188



238

Net income


$

1,105


$

1,708








Diluted earnings per common share


$

1.20


$

1.85








Average shares outstanding:







   Basic



910



907

   Diluted



917



916








Cash dividends declared per common share


$

1.30


$

1.24








Supplemental Information

(Quarterly, except as noted)








Provision for income taxes is based on the following:




Operating taxes (calculated using the estimated annual effective tax rate)


$

176


$

276

Discrete tax items



12



(38)

Provision for income taxes (effective taxes)


$

188


$

238








A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend

equivalents. Diluted EPS is calculated using the following:

Net income


$

1,105


$

1,708

Income allocated to RSUs



(5)



(9)

Income allocated to common stock for diluted EPS


$

1,100


$

1,699

 

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Balance Sheets


March 31,

(In millions, except par value)


2024


2023

Assets







Current assets:







   Cash and cash equivalents


$

2,483


$

4,477

   Short-term investments



7,910



5,068

   Accounts receivable, net of allowances of ($20) and ($13)



1,671



1,877

   Raw materials



417



378

   Work in process



2,129



1,850

   Finished goods



1,537



1,060

   Inventories



4,083



3,288

   Prepaid expenses and other current assets



1,301



313

   Total current assets



17,448



15,023

Property, plant and equipment at cost



13,739



10,791

   Accumulated depreciation



(3,297)



(3,126)

   Property, plant and equipment



10,442



7,665

Goodwill



4,362



4,362

Deferred tax assets



821



486

Capitalized software licenses



231



140

Overfunded retirement plans



169



189

Other long-term assets



1,412



1,355

Total assets


$

34,885


$

29,220








Liabilities and stockholders' equity







Current liabilities:







   Current portion of long-term debt


$

1,349


$

500

   Accounts payable



551



952

   Accrued compensation



399



394

   Income taxes payable



378



372

   Accrued expenses and other liabilities



876



686

   Total current liabilities



3,553



2,904

Long-term debt



12,840



9,626

Underfunded retirement plans



111



123

Deferred tax liabilities



55



73

Other long-term liabilities



1,343



1,251

Total liabilities



17,902



13,977

Stockholders' equity:







   Preferred stock, $25 par value. Shares authorized ? 10; none issued



?



?

   Common stock, $1 par value. Shares authorized ? 2,400; shares issued ? 1,741



1,741



1,741

   Paid-in capital



3,439



3,016

   Retained earnings



52,199



50,930

   Treasury common stock at cost







   Shares: March 31, 2024 ? 831; March 31, 2023 ? 833



(40,193)



(40,192)

   Accumulated other comprehensive income (loss), net of taxes (AOCI)



(203)



(252)

Total stockholders' equity



16,983



15,243

Total liabilities and stockholders' equity


$

34,885


$

29,220

 

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES


Consolidated Statements of Cash Flows


For Three Months Ended

March 31,

(In millions)


2024


2023

Cash flows from operating activities







   Net income


$

1,105


$

1,708

   Adjustments to net income:







   Depreciation



346



265

   Amortization of capitalized software



16



16

   Stock compensation



106



104

   Gains on sales of assets



(129)



?

   Deferred taxes



(71)



(8)

   Increase (decrease) from changes in:







   Accounts receivable



116



18

   Inventories



(84)



(531)

   Prepaid expenses and other current assets



(24)



(4)

   Accounts payable and accrued expenses



(77)



(124)

   Accrued compensation



(444)



(407)

   Income taxes payable



212



185

   Changes in funded status of retirement plans



17



6

   Other



(72)



(68)

Cash flows from operating activities



1,017



1,160








Cash flows from investing activities







   Capital expenditures



(1,248)



(982)

   Proceeds from asset sales



192



1

   Purchases of short-term investments



(4,864)



(3,013)

   Proceeds from short-term investments



2,631



4,026

   Other



(40)



(4)

Cash flows from investing activities



(3,329)



28








Cash flows from financing activities







   Proceeds from issuance of long-term debt



2,980



1,397

   Dividends paid



(1,183)



(1,125)

   Stock repurchases



(3)



(103)

   Proceeds from common stock transactions



65



85

   Other



(28)



(15)

Cash flows from financing activities



1,831



239








Net change in cash and cash equivalents



(481)



1,427

Cash and cash equivalents at beginning of period



2,964



3,050

Cash and cash equivalents at end of period


$

2,483


$

4,477

 

Segment results 

(In millions)


Q1 2024


Q1 2023


Change?

Analog:









   Revenue


$

2,836


$

3,289


(14) %

   Operating profit


$

1,008


$

1,574


(36) %

Embedded Processing:









   Revenue


$

652


$

832


(22) %

   Operating profit


$

105


$

237


(56) %

Other:









   Revenue


$

173


$

258


(33) %

   Operating profit*


$

173


$

123


41 %


     * Includes restructuring charges/other.

 

Non-GAAP financial information

This release includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in accordance with GAAP. Free cash flow was calculated by subtracting capital expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from operations).

We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are supplemental to the comparable GAAP measures.

Reconciliation to the most directly comparable GAAP measures is provided in the table below.



For 12 Months Ended

March 31,



(In millions)


2024


2023


Change?

Cash flow from operations (GAAP)


$

6,277


$

7,736


(19) %

Capital expenditures



(5,337)



(3,336)



Free cash flow (non-GAAP)


$

940


$

4,400


(79) %










Revenue


$

16,801


$

19,502












Cash flow from operations as a percentage of revenue (GAAP)



37.4 %



39.7 %



Free cash flow as a percentage of revenue (non-GAAP)



5.6 %



22.6 %



This release also includes references to operating taxes, a non-GAAP term we use to describe taxes calculated using the estimated annual effective tax rate, a GAAP measure that by definition does not include discrete tax items. We believe the term operating taxes helps to differentiate from effective taxes, which include discrete tax items.

Notice regarding forward-looking statements

This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe TI's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI or our management:

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of TI's most recent Form 10-K. The forward-looking statements included in this release are made only as of the date of this release, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that we will make additional updates with respect to that statement or any other forward-looking statement.

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, tests and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. Our passion to create a better world by making electronics more affordable through semiconductors is alive today, as each generation of innovation builds upon the last to make our technology smaller, more efficient, more reliable and more affordable ? making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. It's what we do and have been doing for decades. Learn more at TI.com.

TXN-G

Texas Instruments Logo. (PRNewsFoto/Texas Instruments Incorporated) (PRNewsfoto/Texas Instruments Incorporated)

 

SOURCE Texas Instruments Incorporated


These press releases may also interest you

at 22:01
In the news release, Nomic Unveils Bitcoin Liquid Staking Token Powered by Babylon's Bitcoin Staking Protocol, issued 10-Apr-2024 by Nomic DAO Foundation over PR Newswire, we are advised by the company that the dateline should read "GEORGE TOWN,...

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...



News published on and distributed by: